Device Trial Radar · NCT03455543
Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy
Last checked: Nov 20, 2026Latest source record: Jul 15, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
182
Actual
Start
Mar 26, 2018
Primary completion
Nov 14, 2018
Study completion Jul 18, 2019
Sponsor
- Lead sponsor
- Regenesis Biomedical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 6, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Part A of this trial is a multi-center, prospective, double-blinded, sham-controlled, randomized clinical trial. Part A will evaluate PEMF treatment compared to sham treatment in patients with painful diabetic distal symmetric peripheral neuropathy (DSPN) when treatment is administered 30 minutes twice daily through a 120-day period (4 months). Part B is a 8-month open-label active treatment extension period designed to collect longer-term data on pain, medication use, quality of life and safety (Part B).Part B of this trial is a an extension period upon completion of Part A.
Conditions
- Diabetic Neuropathy Peripheral
Interventions
Active Provant Therapy SystemDevice
Treatment with active Provant Therapy System
Inactive (sham) Provant Therapy SystemDevice
Treatment with inactive Provant Therapy System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Pain IntensityTime frame: Baseline through 4 months
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Physician's Research Group
Mesa, Arizona
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.